ELEMENTS (5246) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
14 Jul, 2025Executive summary
Quarterly revenue reached a record ¥974 million, up 26% year-over-year, driven by strong LIQUID eKYC and digital ID wallet sales to local governments.
Revenue for the six months ended May 2025 rose 39.9% year-over-year to ¥1,690 million, driven by expansion in core AI cloud services and digital transformation demand.
EBITDA was ¥148 million, with operating income at ¥31 million; excluding Polarify-related costs, adjusted EBITDA was ¥221 million and operating income ¥103 million.
Net loss attributable to shareholders was ¥452 million, mainly due to a ¥659 million impairment loss at Ad Medica.
The company acquired Polarify as a subsidiary during the period, expanding its business scope.
Financial highlights
Cumulative revenue for the first half was ¥1,690 million, up 40% year-over-year; cumulative EBITDA was ¥239 million, and operating income was ¥17 million.
Gross profit for the quarter was ¥750 million (+11% YoY), with a gross margin of 77.0%, down due to digital ID wallet projects.
SG&A expenses rose 32% YoY to ¥719 million, mainly due to Polarify integration costs.
Total assets increased to ¥5,977 million, up ¥1,061 million from the previous year-end, mainly from goodwill and receivables.
Cash and equivalents decreased by ¥689 million to ¥2,057 million at period-end.
Outlook and guidance
Full-year revenue guidance was raised to ¥3,815–4,000 million, reflecting strong business momentum.
Full-year EBITDA is forecast at ¥150–275 million, with an operating loss of ¥225–350 million and a net loss of ¥725–850 million expected due to impairment charges.
Per-share net loss guidance revised to ¥29.52–33.59.
Latest events from ELEMENTS
- Revenue up 53%, net loss widened; FY26 targets profitability and strong authentication growth.5246
Q4 202513 Jan 2026 - Record revenue growth offset by higher costs and net loss; outlook remains unchanged.5246
Q3 202514 Oct 2025 - Revenue up 41%, EBITDA positive, and capital strengthened after Admedica acquisition.5246
Q3 202413 Jun 2025 - Revenue and EBITDA rose sharply, guidance raised, and capital structure strengthened.5246
Q2 202413 Jun 2025 - Revenue up 66% YoY, EBITDA positive, but net loss widened as Polarify was acquired.5246
Q1 20256 Jun 2025 - Record revenue, first full-year profit, and Polarify deal set stage for future growth.5246
Q4 20246 Jun 2025